Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
06/2012
06/27/2012CN101716151B Finasteride oral tablets with quick dissolution and preparation method thereof
06/27/2012CN101693050B Composition containing clerodendranthus spicatus aqueous extract
06/27/2012CN101669988B Extraction process of clerodendranthus spicatus
06/27/2012CN101607058B Application of Chinese medicinal composition in preparing medicament for treating chronic nephritis
06/27/2012CN101601813B Medicament for treating hypertensive renal damage and preparation method thereof
06/27/2012CN101595096B Substituted carbinol compound
06/27/2012CN101500554B Sulfonamide compound or salt thereof
06/27/2012CN101332219B Broken pollen extract and extracting method and use thereof
06/26/2012USRE43497 Anti-MIF antibodies
06/26/2012US8207230 Functional role for cannabinoids in autonomic stability during sleep
06/26/2012US8207158 5HT2c receptor modulators
06/26/2012US8206716 Methods of treating with anti-C5/C5a specific antibodies
06/26/2012US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012CA2508129C Novel x-conotoxin peptides (-i)
06/21/2012WO2012080333A1 Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
06/21/2012WO2012079203A1 Puerarin hydrates, preparation methods and uses thereof
06/21/2012WO2012050944A9 Methods of treating chronic prostatitis/chronic pelvic pain syndrome
06/21/2012US20120157917 High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
06/21/2012US20120157539 Nuclear receptor binding agents
06/21/2012US20120157513 Small Peptide Expression System in Mammalian Cells
06/21/2012US20120157453 Raf inhibitor compounds and methods of use thereof
06/21/2012US20120157452 1h-pyrazolo[3,4-b] pyridine compounds for inhibiting raf kinase
06/21/2012US20120157451 Raf inhibitor compounds and methods of use thereof
06/21/2012US20120157432 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
06/21/2012US20120157430 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/21/2012US20120157423 Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
06/21/2012US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors
06/21/2012US20120157411 2-amino-4-arylthiazole compounds as trpai antagonists
06/21/2012US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists
06/21/2012US20120157386 Neprilysin inhibitors
06/21/2012US20120157383 Neprilysin inhibitors
06/21/2012US20120157382 Pharmaceutical glp-1 compositions having an improved release profile
06/21/2012US20120157371 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
06/21/2012US20120156164 In situ-forming hydrogel for tissue adhesives and biomedical use thereof
06/21/2012US20120156130 Use of her3 binding agents in prostate treatment
06/21/2012CA2821219A1 Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
06/20/2012EP2465579A1 Methods to reduce oxalate concentration by administration of oxalate oxidase crystals
06/20/2012EP2465534A1 Methods for treating conditions associated with MASP-2 dependent complement activation
06/20/2012EP2465504A1 Novel 2,3-diamino-quinazolinone derivatives and their medical use
06/20/2012EP2464626A1 Methods, compounds, and compositions for delivering 1,3-propan ed isulfonic acid
06/20/2012EP2464375A2 Prg4 treatment for interstitial cystitis
06/20/2012EP2464354A1 Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor
06/20/2012EP2364731A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2359855A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP1810979B1 STABILIZED HUMAN IgG4 ANTIBODIES
06/20/2012EP1787647B1 Remedy for glomerular diseases
06/20/2012CN102504989A Male health wine
06/20/2012CN102504024A Antibodies that bind human interleukin-18 and methods of making and using
06/20/2012CN102503959A Tricyclic compounds and preparation method thereof, and medicinal composition containing compounds and application thereof
06/20/2012CN102503932A Novel gas signal molecule donator and preparation method and use thereof
06/20/2012CN102503925A Flavenes (isoflavene) urease inhibitor and synthesis and purpose thereof
06/20/2012CN102503924A Flavane (isoflavane) urease inhibitor and synthesis and use thereof
06/20/2012CN102503922A Flavanol (isobutene flavanol) urease inhibitor and synthesis and application thereof
06/20/2012CN102499934A Application of 3-methoxy xanthone compound in preparation of medicament for preventing and treating hyperuricemia
06/20/2012CN102499924A Application of porphyrin modified by diethylene triamine pentaacetic acid or ethylene diamine tetraacetic acid or ethylene diamine tetraacetic acid
06/20/2012CN102499919A Medicine combination containing low sirolimus dose for treating or preventing fibrotic diseases
06/20/2012CN102499915A Drug with Chinese rhubarb acid compound and preparation method of clathrate compound of Chinese rhubarb acid compound
06/20/2012CN102499541A Red bayberry health-care cushion
06/20/2012CN102091276B Traditional Chinese medicine composition for treating prostatic hypertrophy and preparation method thereof
06/20/2012CN101849997B Traditional Chinese medicine composition capable of reducing blood pressure and tonifying kidney and preparation method and application thereof
06/20/2012CN101491495B Salvianolic acid B magnesium injection, preparation method and use thereof
06/20/2012CN101077338B Nano lanthanum carbonate and orally disintegrating tablet and preparation method
06/19/2012CA2559302C 6-amino-1h-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors
06/19/2012CA2422538C Notch receptor agonists and uses
06/14/2012WO2012079058A2 Use of jasmonate to treat bladder dysfunction
06/14/2012WO2012079043A2 Targeting kidney mesangium with nanoparticles of defined diameter
06/14/2012WO2012078736A2 Fibrinogen and kidney damage
06/14/2012US20120149742 Heterocyclic derivatives as modulators of ion channels
06/14/2012US20120149729 Metalloenzyme inhibitor compounds
06/14/2012US20120149712 Methods for improving kidney function
06/14/2012US20120149700 2-cyanophenyl fused heterocyclic compounds, and compostions and uses thereof
06/14/2012US20120149693 Therapeutic compounds
06/14/2012US20120149673 Inhibitors of store operated calcium release
06/14/2012US20120149671 17alpha, 21-dihydroxypregnene esters as antiandrogenic agents
06/14/2012US20120149655 Use of jasmonate to treat bladder dysfunction
06/14/2012US20120149640 Peptides modulating the activity of igf-1 and the applications of said peptides
06/14/2012US20120148569 Picrorhiza kurroa extract for prevention, elimination and treatment of infection diseases
06/14/2012US20120148488 Targeting Kidney Mesangium With Nanoparticles of Defined Diameter
06/13/2012EP2461815A1 Method of preventing renal disease and treating symptoms thereof
06/13/2012EP1490110B1 Anti-alpha v beta 6 antibodies
06/13/2012EP1235594B1 Inhibition of secretion from non-neuronal cells
06/13/2012CN102498097A Indole derivative and pharmacologically acceptable salt thereof
06/13/2012CN102498096A Indole derivative and pharmacologically acceptable salt thereof
06/13/2012CN102498091A Glycine compound
06/13/2012CN102497874A Pharmaceutical composition containing herbal extracts for preventing or treating nephritis
06/13/2012CN102492596A Body-building and health-care medicinal liquor
06/13/2012CN102488876A External traditional Chinese medicine composition for treating pediatric bedwetting
06/13/2012CN102488860A Traditional Chinese medicine composition for treating chronic uremia and preparation method thereof
06/13/2012CN102488844A Traditional Chinese medicine for regulating function of spleen and kidney
06/13/2012CN102488816A Chinese patent drug for insufficiency of kidney-yang
06/13/2012CN102488806A Renal failure treating Chinese medicinal preparation and preparation method thereof
06/13/2012CN102488805A Method for preparing Shenshuaining preparations with polymeric flocculation and precipitation technology
06/13/2012CN102488743A Chinese traditional medicine composition, preparation method thereof and Chinese traditional medicine preparation
06/13/2012CN102488706A Medicament for preventing and treating urinary calculus and preparation method and application thereof
06/13/2012CN102488700A Application of sargassan to preparation of medicament for preventing and treating urinary calculus
06/13/2012CN102488686A Compound a-keto acid tablet and preparation processes thereof
06/13/2012CN102488682A New application of chlorogenic acid in cancer resisting
06/13/2012CN102488678A Application of embelin to preparation of medicament for treating autoimmune disease
06/13/2012CN102488672A Transdermal drug delivery system of hydrosol
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 562